GAVI Alliance Evaluation Advisory Committee Meeting, 2 June 2010 FINAL MINUTES


1

GAVI Alliance Evaluation Advisory Committee Meeting
2 June 2010
Teleconference

FINAL MINUTES

Finding a quorum of members present 1, the meeting commenced at 15.15 Geneva
time on 2 June 2010.

Given the length of the documents, the Chair of the Evaluati on Advisory Committee
(EAC) propose d that each committee member review the main report and the report
from one of the four strategic goals, along with their fellow committee member as
indicated.

? Strategic Goal 1: Sania Nishtar and Bernhard Schwartlander
? Strategic Goal 2: Stan Foster and Ken Hill
? Strategic Goal 3: George Wellde and Gonzalo Hernandez
? Strategic Goal 4: Minister Sezibera and Zenda Ofir

The Committee Chair suggested focusing on the following questions:
1. To what extent is there adequate descrip tion of the methods used in the
evaluation study?
2. To what extent is there adequate identification and assessment of the
limitations and potential sources of bias in the evaluation study?
3. To what extent do the reports adequately address the study?s defined
evaluation questions?
4. To what extent are the conclusions substantiated by the evaluation?s findings,
and supported through sound and transparent application of appropriate
evaluation methods?

Discussion followed:
1 IFFIm Evaluation

? It was noted that the report for Strategic Goal #3 contains an extensive
discussion of the IFFIm and AMC . The Secretariat is prepared to go to tender
with a Request for Proposals for an evaluation of the IFFIm once the steering
committee for this evaluation is convened and app roves the terms of
reference.

? Although the p reliminary draft report from the Second GAVI Evaluation is not
complete , the section on the IFFIm is almost final. W e could therefore
compare what is addressed in the Second GAVI Evaluation vis -a-vis IFFIm
wit h what we want to get out of the IFFIm evaluation as per the draft ToRs .
The EAC could then ask the IFFIm donors and other stakeholders whether we
have already learned what we wanted to learn about the IFFIm and, if not,
whether the best way to address ou tstanding questions related to the IFFIm is
1 Attendees are listed in Attachment A.

GAVI Alliance Programme and Policy Committee Meeting, 18 -19 May 2010 FINAL MINUTES


1

GAVI Alliance Programme and Policy Committee Meeting
18 -19 May 2010
Geneva, Switzerland

Final Minutes

Finding a quorum of members present 1, the meeting commenced at 9.12 Geneva
time. The Programme and Policy Committee Chair Gustavo Gonzalez -Canali
exp ressed his vision to integrate the Committee?s technical discussions with a
strategic perspective to ensure Committee deliberations continue to be evidence
based, but accessible to a wider cross section of people. He asked committee
members to reflect on this issue and that of roles and responsibilities of the
committee.

The Chair welcomed Anne Schuchat, board representative for Research and
Technical Health Institutes, to her first in -person Committee meeting.

The Committee reviewed the minutes of its meeting on 17 -18 February, 29 March
and 16 April 2010 (Doc #1 in the committee pack).


DECISION
The GAVI Alliance Programme and Policy Committee:
Approved the minutes from 17 -18 February, 29 March and 16 April
2010.

1 Update from the Secretariat
Nina S chwalbe , Managing Director, Policy and Performance provided a summary of
key activities completed since the prior meeting and updated the Committee on
priorities/plans for the rest of 2010. She detailed Board -level committee meetings,
upcoming events, ong oing evaluations, and other key events for the information of
the Committee. Discussion including the following :

? The Evaluation Advisory Committee is actively providing guidance, advice and
input to the GAVI Phase 2 evaluation team. They are also spearhe ading the
development of the Terms of Reference (TOR?s) for the IFFIm evaluation. It is
hoped that the evaluation team will include a partner from a developing country.

? New AMC agreements have been signed. Provisional agreements were made
with Pfizer and full agreements with GSK. 13 Applications have already been
approved and will be supported through the AMC.

1 Participants are listed in Attachment A.

1


GAVI Alliance Programme and Policy Committee Meeting

17-18 February 2010
Geneva, Switzerland

Final Minutes

The meeting commenced 1 at 09.09 Geneva time on 17 February 2010. The PPC will
continue in its present form until the Governance Committee convenes in March, at which
time the membership, including the Chair, will be reconstituted and a new chair appointed.
The Chair summarised the key issues from the November board meeting and noted those
issues requiring follow up by the PPC.

DECISION
The GAVI Alliance Programme and Policy Committee:
Approved the minutes of its meetings on:
? 2 February 2009
? 17 February 2009
? 15-16 April 2009
? 4 June 2009
? 1-2 October 2009

1 Update from the Secretariat
Nina Schwalbe, Managing Director, Policy and Performance provided a summary of key
activities completed since the prior meeting and priorities and plans for 2010 including the
AMC, Board-level committee meetings, upcoming events and ongoing evaluations.
Discussion followed:
? The difference between the PPC and Secretariat Task teams was discussed. For
Secretariat task teams, the Secretariat defines the membership and the terms of
reference. A PPC task team requires PPC approval of membership and TORs. A
request was made for developing country representation on all task teams.
? Industry raised a question on the impact of the eligibility and graduation on the AMC. It
was noted that a meeting was being planned to discuss this with the AMC donors. A
comment was made that it is becoming more difficult to differentiate the subset of AMC
donors from the broader community of GAVI donors. The Secretariat was asked to
share any AMC materials with all donors rather than just the AMC donors.
? The Secretariat clarified that the approved investment cases for Yellow Fever from 2009-
2010 is US$ 44.8 million, for the Meningiti s stockpile from 2009-2013 is $55.1 million and
for the Meningitis A preventative (2009-2010) is $29.5 million. Any further decisions
regarding potential financing for these two vaccines will be determined as part of the
prioritisation process.
1 Attendees are listed in Attachment A.

GAVI Allianc e Audit and Finance Subcommittee Meeting, 1 Feb ruary 2010 FINAL MINUTES
1


GAVI Alliance Audit and Finance Subc ommittee M eeting
1 February 20 10
Geneva, Switzerland & Washington, DC, USA

FINAL Minutes

Finding a quorum of members present 1, the meeting commenced at 15 .15 Washington
time on 1 February 2010 .

1 AMC Firm Order Comm itment
Tony Dutson, Acting CFIO reviewed the financial implications to GAVI?s cash flow and
balance sheet of implementing the firm order commitment associated with the
Pneumococcal Advance Market Commitment ?s (Doc #1 in the subcommittee pack).
Discussion ensued :
? GAVI will have certain financial commitments that underwrite the supply agreements
though there are a number of potential cash flow scenarios . GAVI is looking to work
with its counterparty to execute the most advantageous scenario. As a result, Mr
Dutson provided an upd ate on GAVI?s financial cash flows based on the presented
funding scenarios.
? The Subcommittee considered GAVI?s responsibilities during the firm order
commitment period including the time horizon to fulfil cash transfer notices.
? The Subc ommittee also discussed GAVI and its counterparties? responsibilities after
the conclusion of the firm order commitment period.

DECISION
W ayne Berson and David Crush on behalf of the GAVI Alliance Audit and Finance
Committee:
Acknowledged they had reviewed the financial implications of the AMC
Firm Order Commitment and were comfortable on that basis to move
forward with it .

There being no further business, the meeting was adjourned.



___________________________________
Mr. Kevin Klock, Assistan t Secretary




1 Attendees are listed in Attachment A.

GAVI Alliance Audit and Finance Committee Delegation , 31 January 2010 FINAL MINUTES

1

GAVI Alliance Audit and Finance Committee Delegation
31 January 2010

FINAL Minutes


1 Subcommittee on the AMC Firm Order Commitment

DECISION
In accordance with articles 2.7.3 and 4.8 of the GAVI Alliance By -Laws, and article
3 of the Audit and Finance C ommittee Charter, by electronic consent the GAVI
Alliance Audit and Finance Committee unanimously :
1.1 Delegates to a subcommittee of the Committee Chair and one other
Committee Member the authority to review on behalf of the Committee
the financial implicatio ns of the AMC Firm Order Commitment and to
provide any input it feels is necessary to assist the Executive
Committee in making a funding decision on it. 1



_______________________________
Mr. Kevin Klock, Assistant Secretary
1 Consents are listed in attachment A

GAVI Alliance Audit and Finance Committee teleconference ? 23 March 2009 FINAL MINUTES

1

GAVI Alliance Audit and Finance Committee teleconference
23 March 2009

FINAL Minutes

Finding a quorum of members present
1
1 Pneumococcal Advanced Market Commitment
, the meeting commenced at 10.00 Washington time on 23
March 2009. The Committee selected Wayne Berson to be chair of the meeting.
Tania Cernuschi, AMC Manager and Tim Nielander, General Counsel updated the Committee on the
Pneumococcal Advanced Market Commitment (?AMC?) (Doc #1 in the committee pack). They
confirmed that entering into the AMC agreements sets the parameters for the deal but does not
constitute a funding decision. Further, they noted the procurement services fee for UNICEF was in
line with previous fees.
2
? Approval of AMC-related financial commitments would follow normal IRC/Board
programme approval processes. Finally, Teresa Taube, Director of Financial Reporting reviewed the AMC
Accounting Policy. Discussion followed:
? The Secretariat is allocating headcount for a position devoted to refining the AMC financial
model. (For example, the staff member will evaluate and adjust inflation rate assumptions as
the programme progresses.) The Committee requested updates on the model and underlying
assumptions from time to time.
? After review of the AMC Accounting Policy, the Committee acknowledged the Secretariat?s
intention to implement it.

RECOMMENDATION
The GAVI Alliance Audit and Finance Committee :
1.1 Recommended
1.2
to the Executive Committee that it authorise the CEO on behalf of
the GAVI Alliance to enter into the relevant AMC transaction documents upon the
advice of legal counsel.
Recommended

to the Executive Committee that it approve a supplemental
programme expenditure of US$ 6,000,000 to UNICEF for procurement services.
2 Policies
Kevin Klock, Corporate Governance Officer, reviewed the draft whistleblower, document retention,
and delegation of authority policies (together the ?board policies?) (Doc #2). The purpose of the
whistleblower policy is to provide a way for board member and employee concerns to be raised
without fear of retribution. The document retention policy would outline the rules for preserving
important GAVI documents. A delegation of authority policy would help to define certain
delegations to the officers and other authorised signatories. Having these documents in place is
considered best practice in many jurisdictions. Mr. Klock also tabled the Procurement Policy
enacted by the Board in March 2008 for further consideration (Doc #2). Finally, the Secretariat
tabled a suite of management accounting policies for review (Doc #3). Discussion followed:
1 Participants are listed in Attachment A. 2 Doc #1 erroneou sly listed the US$ 6 million fee as the total fee requested by UNICEF. Instead, this fee
represents a supplemental fee in addition to $3.2 million already approved and expended.